Generic Tazarotene Cream, 0.1% in the Treatment of Acne Vulgaris
Status:
Completed
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
To compare the safety and efficacy profiles of Tazarotene Cream, 0.1 % to the reference
listed drug Tazorac® (tazarotene) Cream, 0.1 % in order to demonstrate bioequivalence, and to
demonstrate superiority of the 2 active creams over that of the cream vehicle (placebo) in
the treatment of acne vulgaris.